nimodipine has been researched along with Cancer of Prostate in 2 studies
Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Perret, S | 1 |
Cantereau, A | 1 |
Audin, J | 1 |
Dufy, B | 1 |
Georgescauld, D | 1 |
Jan, CR | 1 |
Jiann, BP | 1 |
Lu, YC | 1 |
Chang, HT | 1 |
Su, W | 1 |
Chen, WC | 1 |
Yu, CC | 1 |
Huang, JK | 1 |
2 other studies available for nimodipine and Cancer of Prostate
Article | Year |
---|---|
Interplay between Ca2+ release and Ca2+ influx underlies localized hyperpolarization-induced [Ca2+]i waves in prostatic cells.
Topics: Calcium; Calcium Channel Blockers; Calcium Signaling; Cell Polarity; Electric Stimulation; Enzyme In | 1999 |
Effect of the organotin compound triethyltin on Ca2+ handling in human prostate cancer cells.
Topics: Calcium; Calcium-Transporting ATPases; Dose-Response Relationship, Drug; Drug Antagonism; Fura-2; Hu | 2002 |